Minocha, Mukul
Thompson, Corbin G.
Murphy, Alexis
Zhou, Yanchen
Brandl, Christian
Parkes, Amanda
Chen, Xi
Yu, Brian
Martinez, Pablo
Houk, Brett E. https://orcid.org/0000-0002-1979-917X
Article History
Accepted: 28 October 2024
First Online: 26 November 2024
Declarations
:
: This study was funded by Amgen Inc.
: All authors are employees and shareholders of Amgen. The authors have no additional conflicts of interest to declare.
: Electronic records and data are stored at Amgen Inc., Thousand Oaks, CA, USA. Qualified researchers may request data from Amgen clinical studies. Complete details are available at .
: The protocol and amendments were approved by the institutional review board or ethics committee at each participating site. The trial was conducted in accordance with the International Council for Harmonisation Good Clinical Practice guidelines and the principles of the Declaration of Helsinki.
: All patients provided written informed consent.
: Not applicable.
: Not applicable.
: PM, BY, XC, AP, YZ, MM, and BH were responsible for the conception and design of the clinical study. CB performed the bioanalysis. AM, CT, MM, and BH performed the pharmacokinetic analysis and wrote the manuscript. All authors read and approved the final version of this manuscript.